Overview
- The FDA issued a statewide compliance order on Friday, Nov 20, 2026, that takes effect immediately and applies to manufacturers, importers, distributors, retailers, pharmacies, gyms and e‑commerce sellers.
- A coordinated inspection on Friday, Nov 13 seized roughly Rs 1.38–1.39 crore of suspected supplement stock from 17 establishments across six divisions and sent samples to notified laboratories for analysis.
- Pharmacies, gymnasiums and fitness centres must now hold the relevant FSSAI licence or registration to sell supplements and the order covers about 1,100 existing licence holders including 313 manufacturers and 759 relabellers.
- The FDA has banned claims that supplements treat or cure disease, barred doctor endorsements and photographs, warned influencers and online sellers about fines up to ₹10 lakh for misleading ads and signalled licence suspension or recall powers for violators.
- Officials will prioritise testing of sports nutrition, weight‑loss, sexual‑wellness, herbal and imported products for undeclared steroids, NMN and other unauthorised substances and further enforcement will follow food‑analyst reports.